Session 5: The CML frontier
Chair: Prof Timothy Hughes

• Biostats primer for CML clinicians
  (A/Prof John Reynolds)
• TFR trial update
  (Dr David Ross)
• Making TFR mainstream
  (Prof Timothy Hughes)

Biostats primer for CML clinicians
A/Prof John Reynolds, AlfredHealth / Monash University

• Clinical trials and protocole development
• Inference and precision-making - The P-value controversy
• The future - some 'new' statistic tool

TFR in CML - Clinical trials update
Dr David Ross - SA Pathology / University of South Australia

• Treatment-free remission
• TFR experience
• Second TFR
• Predictors of TFR

Making TFR mainstream
Prof. Timothy Hughes, SAHMRI/University of Adelaide

• The TFR Journey
• Risks associated with TFR
• TKI treatment and MR⁴ duration
• TKI recommendation